Cargando…
Changes in Therapy Outcome of Veno-Venous Extracorporeal Membrane Oxygenation for Therapy-Refractory COVID-19 Infections Throughout the Pandemic
PURPOSE: Since the beginning of the current pandemic in late 2019, three accumulations of severe COVID-19 infections (so-called infective waves) caused a fulminant increase in hospitalization. In therapy-refractory patients, veno-venous extracorporeal membrane oxygenation (vv-ECMO) was used since th...
Autores principales: | Immohr, M.B., Hettlich, V., Aubin, H., Dalyanoglu, H., Kindgen-Milles, D., Tudorache, I., Akhyari, P., Lichtenberg, A., Boeken, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988617/ http://dx.doi.org/10.1016/j.healun.2022.01.1327 |
Ejemplares similares
-
ECMO-Kanülierung bei COVID-19: Venovenöse extrakorporale Membranoxygenierung bei COVID-19: Einfluss der Kanülierungsstrategie auf das Therapieergebnis
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022) -
Venovenöse extrakorporale Membranoxygenierung bei COVID-19: Erkenntnisse eines Zentrums aus 96 konsekutiven Fällen
por: Hettlich, Vincent, et al.
Publicado: (2022) -
The quality of afterlife: surviving extracorporeal life support after therapy‐refractory circulatory failure—a comprehensive follow‐up analysis
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021) -
(650) Impact of SARS-CoV-2 Infection on Reactivation of Herpesviridae after Heart and Heart and Kidney Transplantation
por: Immohr, M.B., et al.
Publicado: (2023) -
IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022)